Cost Savings impact and effectiveness of palonosetron institutional maximum dose of 250 mcg (0.25 mg) in pediatric patients less than 17 years of age when used for prevention of chemapy induced nausea and vomiting
Files
Publication Date
4-30-2026
Content Type
poster_control
Recommended Citation
Bustamante, Michelle, "Cost Savings impact and effectiveness of palonosetron institutional maximum dose of 250 mcg (0.25 mg) in pediatric patients less than 17 years of age when used for prevention of chemapy induced nausea and vomiting" (2026). 2026 Baptist Health Academic Conference: The Art and Science of Interprofessional Collaborations. 72.
https://scholarlycommons.baptisthealth.net/bhsf-academic-week-2026/72